PMGC HOLDINGS INC. Stock Option, Exercise Price, Decrease
PMGC HOLDINGS INC. (ELAB) had Stock Option, Exercise Price, Decrease of $1400.00 per share as of 2024-03-06, per its 10-Q filed 2025-08-13.
Financial Statements › Notes › Stockholders' Equity Note
us-gaap:StockOptionExercisePriceDecrease · last filed 2025-08-13
- PMGC HOLDINGS INC. stock option, exercise price, decrease for the quarter ending 2022-12-12 was $5.00.
- PMGC HOLDINGS INC. stock option, exercise price, decrease for the quarter ending 2022-09-30 was $1.34.
| Period end | Stock Option, Exercise Price, Decrease | Stock Option, Exercise Price, Decrease as first filed | Stock Option, Exercise Price, Decrease 0 month | Stock Option, Exercise Price, Decrease 2 month | Stock Option, Exercise Price, Decrease 2 month as first filed | Stock Option, Exercise Price, Decrease 3 month | Stock Option, Exercise Price, Decrease 5 month |
|---|---|---|---|---|---|---|---|
| 2024-03-06 | $1400.00 10-Q · filed 2025-08-13 | $1.00 10-Q · filed 2024-05-15 | |||||
| 2023-07-01 | $7000.00 10-K · filed 2025-03-28 | $5.00 10-Q · filed 2024-11-14 | |||||
| 2023-06-30 | $7000.00 10-K · filed 2025-03-28 | $5.00 10-Q · filed 2024-08-14 | $7000.00 10-K · filed 2025-03-28 | $5.00 10-Q · filed 2023-12-11 | |||
| 2023-02-01 | $7000.00 10-K · filed 2025-03-28 | $5.00 10-Q · filed 2023-12-11 | |||||
| 2023-01-06 | $840.00 10-K · filed 2025-03-28 | $0.60 10-Q · filed 2023-12-11 | |||||
| 2022-12-12 | $5.00 10-K · filed 2024-03-29 | ||||||
| 2022-11-01 | $1.34 10-K · filed 2024-03-29 | ||||||
| 2022-09-30 | $1.34 10-Q · filed 2023-12-11 | ||||||
| 2022-06-01 | $1.34 10-Q · filed 2023-12-11 | ||||||
| 2022-04-25 | $0.60 10-Q · filed 2023-12-11 | $0.60 10-K · filed 2024-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| BriaCell Therapeutics Corp. (BCTX) | $0.037B | ||
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B |